Seidita Aurelio, Latteri Federica, Pistone Mirco, Giuliano Alessandra, Bertoncello Luca, Cavallo Giorgia, Chiavetta Marta, Faraci Francesco, Nigro Alessia, Termini Alessandro, Verona Laura, Ammannato Agnese, Accomando Salvatore, Cavataio Francesca, Lospalluti Maria Letizia, Citrano Michele, Di Liberto Diana, Soresi Maurizio, Mansueto Pasquale, Carroccio Antonio
Internal Medicine Unit, "V. Cervello" Hospital, Ospedali Riuniti "Villa Sofia-Cervello", Via Trabucco, 180, 90146 Palermo, Italy.
Department of Health Promotion Sciences, Maternal and Infant Care, Internal Medicine and Medical Specialties (PROMISE), University of Palermo, Piazza delle Cliniche, 2, 90127 Palermo, Italy.
Nutrients. 2024 Dec 28;17(1):85. doi: 10.3390/nu17010085.
: An increasing number of studies have reported liver involvement in both children and adults with celiac disease (CD). This often manifests as isolated hypertransaminasemia or hepatic steatosis (HS). The aim of this study was to define the prevalence of hypertransaminasemia and HS in a pediatric population with CD before starting a gluten-free diet (GFD) and to analyze how the introduction of a GFD could modify this condition. We also conducted a state-of-the-art literature review of the association between hypertransaminasemia, metabolic dysfunction-associated steatotic liver disease (MASLD) and CD. : We retrospectively reviewed the clinical charts of pediatric CD patients diagnosed in three different pediatric units of Sicily, analyzing clinical, laboratory, ultrasound, and histology data before and 12 months after the introduction of a GFD. : A total of 160 patients (65.0% females, median age 6.4 (0.8-13.2) years) were included; hypertransaminasemia and HS prevalences at diagnosis were 8.1% and 6.1%, respectively. Subjects with hypertransaminasemia were younger ( = 0.01) than those without and had higher frequencies of HS ( = 0.034) and anti-tissue transglutaminase (tTg) immunoglobulin (Ig)G positivity ( = 0.046). Subjects with HS were younger ( = 0.0001) and had a higher frequency of hypertransaminasemia ( = 0.029) compared to non-steatotic ones. After 12 months of a GFD, hypertransaminasemia and HS persisted in 53.8% and 50.0% of patients, respectively. : The prevalences of hypertransaminasemia and HS in Sicilian pediatric CD patients seem to be lower than those reported in other geographical areas. A GFD can reverse the trend of liver involvement, although periods of longer than 12 months may be necessary. However, a GFD has been associated with an increased prevalence of HS, and so regular follow-up involving a nutritionist should be recommended to guide physicians in patient management.
越来越多的研究报告称,患有乳糜泻(CD)的儿童和成人都存在肝脏受累情况。这通常表现为孤立性高转氨酶血症或肝脂肪变性(HS)。本研究的目的是确定在开始无麸质饮食(GFD)之前,儿科CD患者中高转氨酶血症和HS的患病率,并分析引入GFD如何改变这种状况。我们还对高转氨酶血症、代谢功能障碍相关脂肪性肝病(MASLD)和CD之间的关联进行了最新文献综述。
我们回顾性分析了西西里岛三个不同儿科科室诊断的儿科CD患者的临床病历,分析了引入GFD之前和之后12个月的临床、实验室、超声和组织学数据。
共纳入160例患者(女性占65.0%,中位年龄6.4(0.8 - 13.2)岁);诊断时高转氨酶血症和HS的患病率分别为8.1%和6.1%。高转氨酶血症患者比无高转氨酶血症患者年龄更小(P = 0.01),HS发生率更高(P = 0.034),抗组织转谷氨酰胺酶(tTg)免疫球蛋白(Ig)G阳性率更高(P = 0.046)。与非脂肪变性患者相比,HS患者年龄更小(P = 0.0001),高转氨酶血症发生率更高(P = 0.029)。在进行12个月的GFD后,分别有53.8%和50.0%的患者高转氨酶血症和HS持续存在。
西西里岛儿科CD患者中高转氨酶血症和HS的患病率似乎低于其他地理区域报告的患病率。GFD可以扭转肝脏受累的趋势,尽管可能需要超过12个月的时间。然而,GFD与HS患病率增加有关,因此建议进行定期随访,由营养师参与指导医生进行患者管理。